
DEA Warns 'Synthetic Soup' of Fentanyl Mixtures Is Overwhelming Naloxone
Law enforcement reports fentanyl increasingly combined with xylazine, medetomidine, nitazenes and cychlorphine—substances that resist naloxone reversal.
6 articles found
Browse Rainier Rehab's editorial coverage of Data reports. Our writers track federal and state policy, peer-reviewed research, treatment innovations, and frontline reporting from the addiction recovery field. Each article in this collection cites primary sources — government datasets (SAMHSA, NIH, CDC), Medicaid and Medicare bulletins, JAMA and Lancet studies, and on-the-record statements from clinicians, regulators, and people in recovery — so readers can verify claims and dig deeper.
We update this tag whenever new data reports reporting publishes. If you're a researcher, journalist, or family member trying to make sense of substance use disorder treatment, this is the working archive. For a directory of accredited treatment facilities, visit our facilities directory; to compare modalities, see our treatments overview and levels of care guide.

Law enforcement reports fentanyl increasingly combined with xylazine, medetomidine, nitazenes and cychlorphine—substances that resist naloxone reversal.

CDC study reveals gabapentin detection in overdose deaths increased significantly, with 85-90% of cases also involving opioids

Kentucky reports lowest overdose death toll since 2014, with 1,101 fatalities representing 50% decrease from 2021 peak

CDC MMWR report reveals 44 cases of invasive Haemophilus influenzae type b disease in Alaska, Oregon, and Washington, predominantly affecting adults using substances or experiencing homelessness.

CDC data shows historic 37% decline in drug deaths since 2023 peak, but medetomidine, cychlorphine, and nitazenes threaten progress.

Federal health officials alert providers to medetomidine, a potent animal sedative spreading through the illegal opioid supply, causing naloxone-resistant overdoses and life-threatening withdrawal.